Mark Selinger focuses his practice on two areas: the representation of private equity funds and family offices in all aspects of their business, including initial and follow-on investments, refinancings and exit transactions, and the representation of public and private US and Israeli technology and life sciences companies, in public offering, private placement and merger and acquisition transactions.
In his representation of private equity and family office clients, Mark has extensive experience in highly structured investments. He also has experience in the acquisition of assets and companies out of (or in lieu of) bankruptcy, on behalf of financial and strategic investors.
In his representation of public companies, Mark has been involved in several complex cross-border transactions, including the first acquisition of an Israeli NASDAQ-listed company by a US public company under the Israeli merger laws. Mark also advises his public company clients on disclosure and compliance issues arising under US securities laws, including NYSE and NASDAQ regulations.
Mark has also developed significant experience in the representation of companies in the emerging blockchain industry, advising US and non-US companies on the US securities law aspects of initial coin offerings (ICOs) and similar financings, and leading such financings.
Additionally, he is a member of our legal cannabis industry group. Our Cannabis Industry group is a multidisciplinary team of lawyers providing clients with regulatory, litigation, intellectual property, trade and tax services with respect to their investments and participation in the cannabis industry, all subject to the Firm’s obligations under federal and state laws and bar licensure rules.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.